Annual Working Capital
$44.88 M
-$125.09 M-73.60%
December 31, 2023
Summary
- As of February 7, 2025, BTAI annual working capital is $44.88 million, with the most recent change of -$125.09 million (-73.60%) on December 31, 2023.
- During the last 3 years, BTAI annual working capital has fallen by -$160.35 million (-78.13%).
- BTAI annual working capital is now -79.62% below its all-time high of $220.15 million, reached on December 31, 2021.
Performance
BTAI Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$22.23 M
-$14.66 M-39.73%
September 30, 2024
Summary
- As of February 7, 2025, BTAI quarterly working capital is $22.23 million, with the most recent change of -$14.66 million (-39.73%) on September 30, 2024.
- Over the past year, BTAI quarterly working capital has dropped by -$22.64 million (-50.45%).
- BTAI quarterly working capital is now -91.58% below its all-time high of $264.22 million, reached on June 30, 2021.
Performance
BTAI Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
BTAI Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -73.6% | -50.5% |
| 3 y3 years | -78.1% | -90.8% |
| 5 y5 years | +16.5% | -32.9% |
BTAI Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.6% | at low | -90.1% | at low |
| 5 y | 5-year | -79.6% | +75.0% | -91.6% | at low |
| alltime | all time | -79.6% | +1608.6% | -91.6% | +1636.6% |
BioXcel Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $22.23 M(-39.7%) |
| Jun 2024 | - | $36.89 M(-25.4%) |
| Mar 2024 | - | $49.44 M(+10.2%) |
| Dec 2023 | $44.88 M(-73.6%) | $44.88 M(-24.4%) |
| Sep 2023 | - | $59.33 M(-42.7%) |
| Jun 2023 | - | $103.49 M(-30.3%) |
| Mar 2023 | - | $148.51 M(-12.6%) |
| Dec 2022 | $169.97 M(-22.8%) | $169.97 M(-22.1%) |
| Sep 2022 | - | $218.28 M(-3.0%) |
| Jun 2022 | - | $224.93 M(+17.4%) |
| Mar 2022 | - | $191.56 M(-13.0%) |
| Dec 2021 | $220.15 M(+7.3%) | $220.15 M(-9.2%) |
| Sep 2021 | - | $242.33 M(-8.3%) |
| Jun 2021 | - | $264.22 M(+43.2%) |
| Mar 2021 | - | $184.46 M(-10.1%) |
| Dec 2020 | $205.22 M | $205.22 M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $219.79 M(+321.4%) |
| Jun 2020 | - | $52.15 M(-26.9%) |
| Mar 2020 | - | $71.33 M(+178.2%) |
| Dec 2019 | $25.64 M(-33.4%) | $25.64 M(-22.7%) |
| Sep 2019 | - | $33.16 M(+41.1%) |
| Jun 2019 | - | $23.50 M(-24.8%) |
| Mar 2019 | - | $31.27 M(-18.8%) |
| Dec 2018 | $38.51 M(-2761.4%) | $38.51 M(-15.5%) |
| Sep 2018 | - | $45.59 M(-8.3%) |
| Jun 2018 | - | $49.70 M(-4.6%) |
| Mar 2018 | - | $52.10 M(-3700.7%) |
| Dec 2017 | -$1.45 M(+339.8%) | -$1.45 M |
| Dec 2016 | -$329.00 K(-86.1%) | - |
| Jul 2016 | -$2.37 M(+1291.4%) | - |
| Jul 2015 | -$170.50 K(-94.3%) | - |
| Jul 2014 | -$2.97 M | - |
FAQ
- What is BioXcel Therapeutics annual working capital?
- What is the all time high annual working capital for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual working capital year-on-year change?
- What is BioXcel Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly working capital year-on-year change?
What is BioXcel Therapeutics annual working capital?
The current annual working capital of BTAI is $44.88 M
What is the all time high annual working capital for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual working capital is $220.15 M
What is BioXcel Therapeutics annual working capital year-on-year change?
Over the past year, BTAI annual working capital has changed by -$125.09 M (-73.60%)
What is BioXcel Therapeutics quarterly working capital?
The current quarterly working capital of BTAI is $22.23 M
What is the all time high quarterly working capital for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly working capital is $264.22 M
What is BioXcel Therapeutics quarterly working capital year-on-year change?
Over the past year, BTAI quarterly working capital has changed by -$22.64 M (-50.45%)